Literature DB >> 22724547

The history of decoquinate in the control of coccidial infections in ruminants.

M A Taylor1, D J Bartram.   

Abstract

Decoquinate is a quinolone derivative that has been used for over 20 years in the control of coccidiosis in domestic ruminants. Decoquinate treats coccidiosis in lambs and calves and prevents coccidiosis in lambs when administered in feed at a dosage of 1 mg decoquinate/kg bodyweight (b.w.) daily for at least 28 days. It prevents coccidiosis in calves and aids in the prevention of coccidiosis in lambs when administered in calf and ewe feed, respectively, at a dosage of 0.5 mg/kg b.w. daily for at least 28 days. Decoquinate also aids in the prevention of abortions and perinatal losses owing to toxoplasmosis by medication of ewe feed at a dosage of 2 mg/kg b.w. daily, fed continuously for 14 weeks prior to lambing. Several field studies have reported reductions in cryptosporidial oocyst shedding. Decoquinate acts early in the life cycle of Eimeria on sporozoites, released from ingested oocysts, and on first-generation meronts, arresting development and release of merozoites and thus preventing further damage to the intestines owing to the gametocyte stages. Production benefits associated with the use of decoquinate are due mainly to its action as a coccidiostat rather than any effects on diet utilization or ruminal fermentation.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22724547     DOI: 10.1111/j.1365-2885.2012.01421.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  5 in total

1.  Structure-activity relationships of Toxoplasma gondii cytochrome bc1 inhibitors.

Authors:  P Holland Alday; Aaron Nilsen; J Stone Doggett
Journal:  Expert Opin Drug Discov       Date:  2022-08-08       Impact factor: 7.050

2.  Preparation of Decoquinate Solid Dispersion by Hot-Melt Extrusion as an Oral Dosage Form Targeting Liver-Stage Plasmodium Infection.

Authors:  Hongxing Wang; Yinzhou Fan; Li Qin; Zhipeng Cheng; Xueqing Chen; Sumei Zeng; Shuanghong Liang; Ying Tong; Zhu Tao; Yucheng Liu; Xiaorong Liu; Xiaohui Ning; Peiquan Chen; Siting Zhao; Xiaoping Chen
Journal:  Antimicrob Agents Chemother       Date:  2022-06-06       Impact factor: 5.938

3.  Decoquinate liposomes: highly effective clearance of Plasmodium parasites causing severe malaria.

Authors:  Sumei Zeng; Hongxing Wang; Long Tao; Xiaohui Ning; Yinzhou Fan; Siting Zhao; Li Qin; Xiaoping Chen
Journal:  Malar J       Date:  2022-01-24       Impact factor: 2.979

Review 4.  Chemical and Pharmacological Properties of Decoquinate: A Review of Its Pharmaceutical Potential and Future Perspectives.

Authors:  Tainá Santos Souza; Diogo Rodrigo Magalhães Moreira; Henrique Rodrigues Marcelino
Journal:  Pharmaceutics       Date:  2022-06-30       Impact factor: 6.525

5.  The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria.

Authors:  Daniel J Watson; Lizahn Laing; Richard M Beteck; Liezl Gibhard; Richard K Haynes; Lubbe Wiesner
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.